{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:55:09Z","timestamp":1790412909294,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KWF 2015-7914"],"award-info":[{"award-number":["KWF 2015-7914"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.euo.2025.02.013","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T15:54:24Z","timestamp":1746460464000},"page":"1278-1285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk-based Prostate-specific Antigen Monitoring Reduces Follow-up Burden After Radical Prostatectomy"],"prefix":"10.1016","volume":"8","author":[{"given":"Leonor Jane","family":"Paulino Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick C.N.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel J.P.M.","family":"Sedelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berdine L.","family":"Heesterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja K.H.","family":"Aben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambertus","family":"Kiemeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"van Oort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm H.E.","family":"van Melick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.02.013_b0005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.013_b0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057242","article-title":"Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study","volume":"12","author":"Ahlberg","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.euo.2025.02.013_b0015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.013_b0020","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41391-022-00638-y","article-title":"The natural history of a delayed detectable PSA after radical prostatectomy","volume":"26","author":"Szymaniak","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euo.2025.02.013_b0025","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1001\/jama.299.23.2760","article-title":"Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy","volume":"299","author":"Trock","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2025.02.013_b0030","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ajco.13341","article-title":"Early salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: its impact and optimal candidate","volume":"16","author":"Tomita","year":"2020","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.euo.2025.02.013_b0035","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.juro.2009.08.027","article-title":"Radiation therapy after radical prostatectomy: impact on metastasis and survival","volume":"182","author":"Boorjian","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.02.013_b0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2023.05.038","article-title":"European Association of Urology biochemical recurrence risk classification as a decision tool for salvage radiotherapy\u2014a multicenter study","volume":"85","author":"Preisser","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.013_b0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00345-022-04245-3","article-title":"Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy","volume":"41","author":"Blas","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.02.013_b0050","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1002\/cncr.26169","article-title":"The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy","volume":"117","author":"Cooperberg","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2025.02.013_b0055","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/biomedicines11030727","article-title":"Identifying patients in whom the follow-up scheme after robot-assisted radical prostatectomy could be optimized in the first year after surgery: reducing healthcare burden","volume":"11","author":"Veerman","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.euo.2025.02.013_b0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.32900","article-title":"Biochemical recurrence and risk of mortality following radiotherapy or radical prostatectomy","volume":"6","author":"Falagario","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2025.02.013_b0065","doi-asserted-by":"crossref","first-page":"341.e9","DOI":"10.1016\/j.urolonc.2018.04.003","article-title":"Establishment of the optimal follow-up schedule after radical prostatectomy","volume":"36","author":"Matsumoto","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.02.013_b0070","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10147-020-01676-z","article-title":"External validation of the \u201coptimal PSA follow-up schedule after radical prostatectomy\u201d in a new cohort","volume":"25","author":"Yanai","year":"2020","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euo.2025.02.013_b0075","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.euf.2016.11.014","article-title":"The CPC risk calculator: a new app to predict prostate-specific antigen recurrence during follow-up after radical prostatectomy","volume":"4","author":"R\u00f8der","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.02.013_b0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II\u20142020 update: treatment of relapsing and metastatic prostate cancer","volume":"79","author":"Cornford","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.02.013_b0085","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7196189","article-title":"Long-term follow-up after prostatectomy for prostate cancer and the need for active monitoring","volume":"2020","author":"Swanson","year":"2020","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.euo.2025.02.013_b0090","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/bjs\/znad022","article-title":"Oncological surgery follow-up and quality of life: meta-analysis","volume":"110","author":"Wullaert","year":"2023","journal-title":"Br J Surg"},{"key":"10.1016\/j.euo.2025.02.013_b0095","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125000495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:35:04Z","timestamp":1766511304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125000495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2588931125000495"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.02.013","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk-based Prostate-specific Antigen Monitoring Reduces Follow-up Burden After Radical Prostatectomy","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}